Role of Drug – Drug Interactions in the Efficacy and Safety of Clarithromycin Treatment for Helicobacter Pylori Eradication


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

Current risks from resistance, adverse drug reactions, and drug – drug interactions of clarithromycin used as a component of Helicobacter pylori eradication therapy are reviewed. The acid sensitivity of clarithromycin i responsible for the dependence of its pharmacological properties on the efficacy of proton-pump inhibitors, which could be one reason for the resistance of H. pylori to the macrolide. The potential for clarithromycin drug – drug interactions is related to its metabolism by CYP3A4 and strong inhibition of this enzyme.

Авторлар туралы

S. Serebrova

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University (Sechenov University)

Email: kareva.en@1msmu.ru
Ресей, 8/2 Petrovskii Blvd., Moscow, 127051; 8/2 Trubetskaya St., Moscow, 119991

E. Kareva

I. M. Sechenov First Moscow State Medical University (Sechenov University); N. I. Pirogov National Research Medical University

Хат алмасуға жауапты Автор.
Email: kareva.en@1msmu.ru
Ресей, 8/2 Trubetskaya St., Moscow, 119991; 1 Ostrovityanova St., Moscow, 117997

N. Eremenko

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University (Sechenov University)

Email: kareva.en@1msmu.ru
Ресей, 8/2 Petrovskii Blvd., Moscow, 127051; 8/2 Trubetskaya St., Moscow, 119991

A. Prokof’ev

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University (Sechenov University)

Email: kareva.en@1msmu.ru
Ресей, 8/2 Petrovskii Blvd., Moscow, 127051; 8/2 Trubetskaya St., Moscow, 119991

D. Kurguzova

I. M. Sechenov First Moscow State Medical University (Sechenov University)

Email: kareva.en@1msmu.ru
Ресей, 8/2 Trubetskaya St., Moscow, 119991

V. Drozdov

I. M. Sechenov First Moscow State Medical University (Sechenov University)

Email: kareva.en@1msmu.ru
Ресей, 8/2 Trubetskaya St., Moscow, 119991

N. Lazareva

I. M. Sechenov First Moscow State Medical University (Sechenov University)

Email: kareva.en@1msmu.ru
Ресей, 8/2 Trubetskaya St., Moscow, 119991

I. Komissarenko

A. I. Evdokimov Moscow State University of Medicine and Dentistry

Email: kareva.en@1msmu.ru
Ресей, 20/1 Delegatskaya St., Moscow, 127473

A. Starodubtsev

I. M. Sechenov First Moscow State Medical University (Sechenov University)

Email: kareva.en@1msmu.ru
Ресей, 8/2 Trubetskaya St., Moscow, 119991

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Springer Science+Business Media, LLC, part of Springer Nature, 2019